CVS Health

But Dr. William Shrank, chief scientific officer at CVS Health, estimates they will cost$ 7000 to$ 12000 a year.

但CVS健康公司（CVS Health）的首席科学官威廉·史兰克（William Shrank）估计，服用这种药物一年将需要7000至1.2万美元。

Executives at CVS Health, a leading pharmacy benefits manager, recently said that PCSK9 inhibitors might cost$ 7000 to$ 12000 a year and would strain health care budgets because so many people might use them.

CVS健康公司（CVS Health）是美国名列前茅的一家医药福利管理公司，其高管最近表示，在PCSK9抑制剂上的年花费预计达7000美元至12000美元，由于使用者人数众多，它将给医疗预算带来沉重的压力。